Project Details
Description
Randomized, double-blind, placebo-controlled study of the safety, tolerability, pharmacokinetics and pharmacodynamics of ascending repeated doses of SAR156597 in patients with idiopathic pulmonary fibrosis (IPF).
| Status | Finished |
|---|---|
| Effective start/end date | 2/15/12 → 2/28/14 |
Funding
- SANOFI-AVENTIS US
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.